Prof. Lester Thompson, M.D.
| Clearing Out the House: Clear-cell Salivary Gland Tumors Session 2 |
May 2 @ 21:00 – 21:30 IST
Prof. Lester D.R. Thompson, M.D.
Distinguished Pathologist and Educator in Head and Neck Pathology
Prof. Lester D.R. Thompson is an internationally recognized leader in Head and Neck Pathology, with a career spanning over thirty years. He currently leads Head and Neck Pathology Consultations in Woodland Hills, California. He has held esteemed roles, including Founding and Co-Editor-in-Chief of the Head and Neck Pathology journal and Editorial Board Member for the World Health Organization’s Classification of Tumours series.
Dr. Thompson has contributed extensively to advancing pathology through his authorship of over 12 books and 425+ peer-reviewed publications. His expertise encompasses many diseases, significantly contributing to the thyroid, salivary gland, sinonasal tract, and neuroendocrine pathology. Notably, he has served on the editorial boards of several leading pathology journals and played a pivotal role in redefining diagnostic criteria and staging systems in tumor classification.
Dr. Thompson’s distinguished service extends beyond academia. A retired United States Navy Medical Corps Captain, he has been honored with multiple military commendations for exemplary service. His accolades include the Vincent Hyams Award, Leon Barnes Award, and the British Medical Association Book Award, underscoring his profound impact on pathology and medicine.
At IODCPC25, Prof. Thompson will share his unparalleled expertise, offering insights into the latest advances and challenges in diagnosing and managing head and neck diseases.
About the Lecture:
Salivary gland neoplasms are a very small proportion of most general surgical pathology services and, as such, can cause diagnostic difficulties. Clear cell tumors can especially be challenging when core needle biopsies are utilized, and limited material is present. Recognizing the variations inherent in each salivary gland tumor category and thinking of a logical approach to clear cell tumors allows for an accurate diagnosis to be rendered in most cases using a limited immunohistochemistry panel approach to diagnosis. In selected cases, further molecular investigation will help guide diagnosis and treatment.